Ann: AusCann Releases Low-dose Form Capsule, page-30

bit looks interesting... already onto phase 2 trials is a good sign and I read the brief on HIV-1 showing a significant response... very hopeful. I noted they're also looking at HCV and possibly HBV. I'm no longer up to date with HCV treatment - I must look at this next - but if this shows promise then HBV could be possible and this has so far been totally unresponsive to anti-retrovial treatments. Massive market. and very positive for treatment of those who, like my friend who died from HBV complications, have no hope of recovery.

thanks for the tip fishman

PS I've called myself da Physchemon for many years. Glad to meet a fellow fish.

Scott.